GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kee Song Bio-Technology Holdings Ltd (ROCO:1258) » Definitions » Revenue

Kee Song Bio-Technology Holdings (ROCO:1258) Revenue : NT$2,698 Mil (TTM As of Mar. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Kee Song Bio-Technology Holdings Revenue?

Kee Song Bio-Technology Holdings's revenue for the three months ended in Mar. 2023 was NT$734 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2023 was NT$2,698 Mil. Kee Song Bio-Technology Holdings's Revenue per Share for the three months ended in Mar. 2023 was NT$19.93. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was NT$73.21.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Kee Song Bio-Technology Holdings Revenue Historical Data

The historical data trend for Kee Song Bio-Technology Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kee Song Bio-Technology Holdings Revenue Chart

Kee Song Bio-Technology Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,835.04 3,039.33 2,545.05 2,288.84 2,570.54

Kee Song Bio-Technology Holdings Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 606.36 651.25 588.38 724.54 733.89

Competitive Comparison of Kee Song Bio-Technology Holdings's Revenue

For the Packaged Foods subindustry, Kee Song Bio-Technology Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kee Song Bio-Technology Holdings's Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kee Song Bio-Technology Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where Kee Song Bio-Technology Holdings's Revenue falls into.



Kee Song Bio-Technology Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$2,698 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kee Song Bio-Technology Holdings  (ROCO:1258) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Kee Song Bio-Technology Holdings Revenue Related Terms

Thank you for viewing the detailed overview of Kee Song Bio-Technology Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Kee Song Bio-Technology Holdings (ROCO:1258) Business Description

Traded in Other Exchanges
N/A
Address
Songjiang Road, 104, 8th Floor, No. 51, Zhongshan District, Taipei, TWN, 104
Kee Song Bio-Technology Holdings Ltd is engaged in the processing and distribution of meat products. This includes poultry, production, and sale of chicken as well as the trade of frozen meat and prepared food. It has two reportable segments; the Poultry and processing distribution segment which is engaged in the business of importing, slaughtering, wholesaling, and retailing poultry and consumable goods of all kinds; and the Poultry farming segment involved in the business of poultry farming. It derives a majority of its revenue from the poultry farming segment.

Kee Song Bio-Technology Holdings (ROCO:1258) Headlines

No Headlines